Migrastatin analog compositions and uses thereof
US8202911B2 · kind B2 · utility
2Cited by
6References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 21, 2011 |
| Grant date | Jun 19, 2012 |
| Priority date | — |
| Expiry date | Mar 21, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the present invention provides pharmaceutical compositions comprising a therapeutically effective amount of a compound of general formula (I), In another aspect, the present invention provides a method for treating breast tumor metastasis in a subject comprising administering to a subject in need thereof a therapeutically effective amount of the inventive composition described directly above and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.